You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VERA Sale Disclosure
Fordyce Marshall · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$649.64K
Fordyce Marshall President And CEO
VERA
Vera Therapeutics
VERA
Transaction date
Sep 2, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed 2 days later
VERA daily price context
Close on/before transaction
$35.66
Sep 2, 2026
First close after public filing
$35.28
Sep 8, 2026
30-day return after filing
-15.45%
Through Oct 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 18,500 shares @ $35.12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001859453-26-000014
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$703.23K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vera Therapeutics, Inc. VERA | Exercise | Sep 2, 2026 | $53.59K |
| Vera Therapeutics, Inc. VERA Current | Sale | Sep 2, 2026 | $649.64K |
| Vera Therapeutics, Inc. VERA | Exercise | Sep 2, 2026 | $0 |